arginyl-glycyl-aspartic acid has been researched along with 10-hydroxycamptothecin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Q; Liu, J; Luo, X; Yang, Z; Zhang, X | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and 10-hydroxycamptothecin
| Article | Year |
|---|---|
Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Survival; Humans; Lipids; Materials Testing; MCF-7 Cells; Molecular Targeted Therapy; Nanocapsules; Oligopeptides; Polymers | 2013 |